Sarolaner is an ectoparasiticide veterinary medication for the treatment of flea and tick infestations in dogs and cats. Sarolaner was developed by the American drug company Zoetis and is an active ingredient in Zoetis' medications: Simparica, Simparica Trio and Revolution Plus.
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.